SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 29.87-0.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: opalapril who wrote (8442)1/22/1999 7:23:00 PM
From: aknahow  Read Replies (1) of 17367
 
Mr. Pril, once again you are wrong! Money does not rest, it compounds.

The so called redesign probably was letting us know that they were looking for total deaths.

Not at all sure why you think XOMA is doing something wrong. I would not want I.R. to act "like its' a wonder drug."

Hardly like a White House spin. There was every reason to believe trial would terminate in two years. We are looking at a minor continuation of the trial. Really what's the big deal. Learning why the trial was being continued was important and positive. Difficult to understand why any one long the stock as we both are would be unhappy. I think this is the best news I have heard in a long time.

BTW you come very close to saying you have a disturbed mind. I therefore hope that you are not offended that I still have an interest in what opalaprill means. I tried Texas Dudes suggestion re the LGND board but got sick looking for the answer to the secret.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext